EG19644A - Process for preparing of tricyclic amines as novel cholinesterase inhibitros - Google Patents

Process for preparing of tricyclic amines as novel cholinesterase inhibitros

Info

Publication number
EG19644A
EG19644A EG7591A EG7591A EG19644A EG 19644 A EG19644 A EG 19644A EG 7591 A EG7591 A EG 7591A EG 7591 A EG7591 A EG 7591A EG 19644 A EG19644 A EG 19644A
Authority
EG
Egypt
Prior art keywords
inhibitros
preparing
tricyclic amines
cholinesterase
novel
Prior art date
Application number
EG7591A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG19644A publication Critical patent/EG19644A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG7591A 1990-02-08 1991-02-07 Process for preparing of tricyclic amines as novel cholinesterase inhibitros EG19644A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47692890A 1990-02-08 1990-02-08

Publications (1)

Publication Number Publication Date
EG19644A true EG19644A (en) 1995-08-30

Family

ID=23893824

Family Applications (1)

Application Number Title Priority Date Filing Date
EG7591A EG19644A (en) 1990-02-08 1991-02-07 Process for preparing of tricyclic amines as novel cholinesterase inhibitros

Country Status (21)

Country Link
EP (1) EP0441517A3 (US20100056889A1-20100304-C00004.png)
JP (1) JPH07119214B2 (US20100056889A1-20100304-C00004.png)
KR (1) KR950013562B1 (US20100056889A1-20100304-C00004.png)
CN (1) CN1054600A (US20100056889A1-20100304-C00004.png)
AU (1) AU631723B2 (US20100056889A1-20100304-C00004.png)
BR (1) BR9100519A (US20100056889A1-20100304-C00004.png)
CA (1) CA2035805C (US20100056889A1-20100304-C00004.png)
CS (1) CS29991A2 (US20100056889A1-20100304-C00004.png)
DE (1) DE9101348U1 (US20100056889A1-20100304-C00004.png)
EG (1) EG19644A (US20100056889A1-20100304-C00004.png)
FI (1) FI910592A (US20100056889A1-20100304-C00004.png)
HU (1) HUT70051A (US20100056889A1-20100304-C00004.png)
IE (1) IE910402A1 (US20100056889A1-20100304-C00004.png)
IL (1) IL97140A (US20100056889A1-20100304-C00004.png)
NO (1) NO177534C (US20100056889A1-20100304-C00004.png)
NZ (1) NZ237040A (US20100056889A1-20100304-C00004.png)
PL (2) PL166757B1 (US20100056889A1-20100304-C00004.png)
PT (1) PT96681A (US20100056889A1-20100304-C00004.png)
TW (1) TW197442B (US20100056889A1-20100304-C00004.png)
YU (1) YU21391A (US20100056889A1-20100304-C00004.png)
ZA (1) ZA91916B (US20100056889A1-20100304-C00004.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
TW263504B (US20100056889A1-20100304-C00004.png) * 1991-10-03 1995-11-21 Pfizer
TW248556B (US20100056889A1-20100304-C00004.png) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
CN1163224C (zh) 1998-09-30 2004-08-25 武田药品工业株式会社 改善膀胱排泄能力的药物
KR20050084890A (ko) 2002-10-30 2005-08-29 머크 프로스트 캐나다 앤드 캄파니 피리도피롤리진 및 피리도인돌리진 유도체
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
JP6557441B1 (ja) * 2017-09-07 2019-08-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 五環式化合物
TWI821537B (zh) 2019-03-05 2023-11-11 日商衛材R&D企管股份有限公司 五環式雜環化合物
BR112021015979A2 (pt) 2019-03-05 2021-10-05 Eisai R&D Management Co., Ltd. Sal de composto pentacíclico e cristal do mesmo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910947A (en) * 1969-07-24 1975-10-07 Sandoz Ag Preparation of imidazo{8 2,1-a{9 isoindoles
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
AU7087991A (en) 1991-08-29
EP0441517A2 (en) 1991-08-14
FI910592A0 (fi) 1991-02-07
FI910592A (fi) 1991-08-09
DE9101348U1 (de) 1991-06-06
YU21391A (sh) 1994-01-20
KR910015580A (ko) 1991-09-30
AU631723B2 (en) 1992-12-03
HUT70051A (en) 1995-09-28
PL288977A1 (en) 1992-01-13
HU910406D0 (en) 1991-08-28
CA2035805C (en) 1995-06-27
CN1054600A (zh) 1991-09-18
NO910473L (no) 1991-08-09
JPH04234845A (ja) 1992-08-24
PT96681A (pt) 1991-10-31
NZ237040A (en) 1993-10-26
BR9100519A (pt) 1991-10-29
IL97140A (en) 1995-07-31
ZA91916B (en) 1992-09-30
TW197442B (US20100056889A1-20100304-C00004.png) 1993-01-01
KR950013562B1 (ko) 1995-11-09
EP0441517A3 (en) 1992-08-19
PL166757B1 (pl) 1995-06-30
IL97140A0 (en) 1992-05-25
NO910473D0 (no) 1991-02-07
JPH07119214B2 (ja) 1995-12-20
PL167078B1 (pl) 1995-07-31
IE910402A1 (en) 1991-08-14
NO177534B (no) 1995-06-26
CS29991A2 (en) 1991-09-15
NO177534C (no) 1995-10-04

Similar Documents

Publication Publication Date Title
EG18398A (en) Process for preparing of piperazinyl-heterocyclic compounds
EP0514692A3 (en) Process for the preparation of amines
EG19905A (en) Process for preparing of antimalarial compositions
HU913346D0 (en) Process for the production of aromatic amines
HU913579D0 (en) Process for the production of new tricyclic compounds
HUT57702A (en) Process for producing alkyl amines
EG19644A (en) Process for preparing of tricyclic amines as novel cholinesterase inhibitros
EP0448194A3 (en) Process for production of polyarylenesulfides
DE3569514D1 (en) Process for the preparation of nitroxyls of sterically hindered amines
EP0484908A3 (en) Microbiological process for the preparation of hydroxylated pyrazinederivatives
HU901593D0 (en) Process for the preparation of novel compounds
EP0431451A3 (en) Process for the preparation of amines
EP0325892A3 (en) Process for the preparation of halogenated primary amines
HU912107D0 (en) Process for the production of tricyclic compounds containing heteroatoms
EP0453885A3 (en) Process for the preparation of aromatic amines
EP0424738A3 (en) Process for the preparation of amines
EP0457730A3 (en) Process for preparation of thioderivatives of alkylhydroxyanilinotriazine
EP0476649A3 (en) Process for the preparation of carbapeneme compounds
EP0393350A3 (en) Process for the preparation of amines
CS284190A3 (en) Process for preparing nitrobenzenes
HU912511D0 (en) Process for the production of tricyclic heterocyclic compounds
HU895870D0 (en) Process for preparing of earthworms
AU6348086A (en) Process for preparing mixed alkyl amines
PL241968A1 (en) Process for preparing novel derivatives of quinazoline
EP0508119A3 (en) Novel process for the preparation of amine-terminated compounds